Company / R&D per Share
TransMedics Group, Inc. R&D per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.05
FY2025
5-year range
$0.82 / $2.05
FY2021-FY2025
Trend
+19.9%
vs FY2024
Sector context
#45 of 103
Health Care
What the data says
At $2.05, TransMedics Group, Inc.'s r&d per share ranks #45 of 103 in the Health Care sector. R&D per Share has increased for 4 consecutive years, from $0.82 in FY2021 to $2.05 in FY2025.
Based on SEC 10-K filings.
2.05 in FY2025 with a 5-year CAGR of +9.2%.
Improved from $1.12 to $2.05 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +28.6%
- 5-Year CAGR
- +9.2%
- 10-Year CAGR
- -
Sector benchmark
#45 of 103 in Health CareTop 44% of 103This company $2.05 Sector average $2.13
▼
-3.7% below sector average
Key checks
Key Insights
- TransMedics Group, Inc.'s r&d per share has grown for 4 consecutive years.
- In FY2025, r&d per share increased 19.9% year-over-year.
- Ranks #45 out of 103 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2019.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.05 | +19.9% |
| FY2024 | $1.71 | +52.7% |
| FY2023 | $1.12 | +16.3% |
| FY2022 | $0.96 | +17.5% |
| FY2021 | $0.82 | -38.1% |
| FY2020 | $1.33 | -91.1% |
| FY2019 | $14.87 | +45.5% |
| FY2018 | $10.22 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026